RON - The Con in Colorectal Carcinoma
The Open Colorectal Cancer Journal · 2012
DOI: 10.2174/1876820201205010015 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Colorectal Cancer Journal, 2012. Verfasst von Shikha Tarang. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
The recepteur d'origine nantais (RON) is a member of MET family of receptor tyrosine kinase (RTKs), an overexpression of which has been observed in several cancers.The expression of RON gene is required during embryonic development and also plays critical roles in regulating macrophage inflammatory response.In CRC, the overexpression of moderate RON activity contributes to their oncogenic potential by regulating several key processes such as proliferation, motility and resistance to apoptosis.Interestingly, an aberrant RON expression is often associated with the generation of several splice variants with unique transforming activities.The targeting of RON signaling pathway by the use of monoclonal antibodies and small-molecule inhibitors has shown promising therapeutic results in animal models.The present article aims at summarizing the current understanding of RON kinase in CRC.
Zitieren
APA
Tarang, S. (2012). RON - The Con in Colorectal Carcinoma. The Open Colorectal Cancer Journal. https://doi.org/10.2174/1876820201205010015
Vancouver
Tarang S. RON - The Con in Colorectal Carcinoma. The Open Colorectal Cancer Journal. 2012. doi:10.2174/1876820201205010015
BibTeX
@article{Tarang2012,
author = {Tarang, Shikha},
title = {RON - The Con in Colorectal Carcinoma},
journal = {The Open Colorectal Cancer Journal},
year = {2012},
doi = {10.2174/1876820201205010015}
}
EUVIMED